Genmab A/S Stock Nasdaq
Stocks
GMAB
US3723032062
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.52 USD | -1.66% |
|
+0.55% | -7.40% |
| Market Cap | 115B 17.58B 15.32B 14.3B 13.16B 24.67B 1,682B 25.29B 169B 66.29B 835B 66.02B 64.59B 2,871B | P/E 2026 * |
24.4x | P/E 2027 * | 16.9x |
|---|---|---|---|---|---|
| Enterprise Value | 134B 20.56B 17.91B 16.72B 15.39B 28.84B 1,967B 29.57B 198B 77.52B 977B 77.2B 75.53B 3,357B | EV / Sales 2026 * |
4.74x | EV / Sales 2027 * | 3.81x |
| Free-Float |
95.41% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Genmab A/S
| 1 day | -1.66% | ||
| 1 week | +0.55% | ||
| Current month | +3.82% | ||
| 1 month | +9.19% | ||
| 3 months | +6.46% | ||
| 6 months | -13.39% | ||
| Current year | -7.40% |
| 1 week | 28.33 |  | 29.38 |
| 1 month | 27.33 | | 29.8 |
| Current year | 23.62 | | 35.43 |
| 1 year | 21 | | 35.43 |
| 3 years | 17.24 | | 41.58 |
| 5 years | 17.24 | | 49.07 |
| 10 years | 12.1 | | 49.07 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.66% | +0.55% | - | - | 17.86B | |
| +0.47% | +2.03% | +51.54% | +70.84% | 55.01B | |
| +2.83% | +0.04% | +38.07% | +82.59% | 54.24B | |
| +0.54% | +0.67% | -17.59% | -13.47% | 23.38B | |
| -0.97% | -5.06% | +1.35% | +383.00% | 22.57B | |
| +2.07% | +1.44% | +23.06% | -9.05% | 20.19B | |
| -2.14% | -2.72% | +30.26% | +536.72% | 15.5B | |
| -3.14% | -8.09% | +160.68% | +292.18% | 14.2B | |
| -2.09% | -1.41% | +24.65% | +178.74% | 14.2B | |
| +1.50% | +0.02% | +85.91% | +166.11% | 12.42B | |
| Average | -0.26% | -0.57% | +44.21% | +187.52% | 25.75B | |
| Weighted average by Cap. | +0.37% | -0.28% | +39.50% | +144.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.25B 4.33B 3.78B 3.52B 3.24B 6.08B 414B 6.23B 41.73B 16.34B 206B 16.27B 15.92B 708B | 33.18B 5.09B 4.43B 4.14B 3.81B 7.14B 487B 7.32B 49.02B 19.19B 242B 19.11B 18.7B 831B |
| Net income | 4.82B 739M 644M 601M 553M 1.04B 70.66B 1.06B 7.11B 2.78B 35.09B 2.77B 2.71B 121B | 7.05B 1.08B 943M 880M 810M 1.52B 104B 1.56B 10.42B 4.08B 51.41B 4.06B 3.98B 177B |
| Net Debt | 19.4B 2.98B 2.59B 2.42B 2.23B 4.18B 285B 4.28B 28.66B 11.22B 141B 11.18B 10.93B 486B | 11.82B 1.81B 1.58B 1.47B 1.36B 2.54B 173B 2.61B 17.46B 6.84B 86.14B 6.81B 6.66B 296B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/07/26 | $28.52 | -1.66% | 1,160,555 |
| 28/07/26 | $29.00 | +0.69% | 2,212,644 |
| 27/07/26 | $28.80 | -0.24% | 1,526,784 |
| 24/07/26 | $28.87 | -1.03% | 1,676,219 |
| 23/07/26 | $29.17 | +1.11% | 1,135,422 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
